Weigao Blood Clean: Issuance of shares to acquire 100% equity of Puri Medical approved by Shanghai Stock Exchange.

Weigao Blood Cleanse announced that the company intends to acquire 100% equity of Shandong Weigao Purui Pharmaceutical Packaging Co., Ltd. through the issuance of shares. On August 10, the results of the Shanghai Stock Exchange's restructuring committee review indicated that this transaction meets the restructuring conditions and information disclosure requirements. However, this transaction still requires approval for registration from the China Securities Regulatory Commission before it can be implemented. Whether registration can be obtained and the timeline for this are both uncertain. The company will disclose progress in a timely manner and remind investors to pay attention to risks.